Lower GI Bleeding Management (ACG 2023)
Lower GI Bleeding Management (ACG 2023): START: Acute Lower GI Bleeding → Initial Assessment & Resuscitation → Hemodynamically Stable? → Hemodynamically...
Interactive Decision Tree
Algorithm Steps
- ▶Start
START: Acute Lower GI Bleeding
Hematochezia or maroon stool
- ●Action
Initial Assessment & Resuscitation
Stabilize patient
- 2 large-bore IVs
- Type and screen/crossmatch
- CBC, BMP, coags, LFTs
- Rectal exam to confirm hematochezia
- Consider NG tube/EGD if brisk bleeding (r/o upper source)
- ◆Decision
Hemodynamically Stable?
Assess stability
- UNSTABLE: SBP <90, HR >100, signs of shock
- STABLE: Normal vitals, no active bleeding
- ⚠Warning
Hemodynamically Unstable
Aggressive resuscitation
- Crystalloid resuscitation
- Blood transfusion (target Hgb ≥7, or ≥8 if CAD)
- Consider massive transfusion if ongoing
- Correct coagulopathy
- Rule out upper GI source with NG aspirate or EGD
- ◆Decision
Colonoscopy Timing
Based on risk and stability
- URGENT (<24h): Hemodynamic instability, high-risk features
- ELECTIVE (24-72h): Stable, low-risk patients
- ●Action
Bowel Preparation
Prep before colonoscopy
- Polyethylene glycol-based prep (4-6L over 3-4 hrs)
- NG tube if unable to tolerate oral
- Adequate prep improves diagnostic yield
- ●Action
Colonoscopy
Diagnostic and therapeutic
- Identify bleeding source
- Common sources: Diverticulosis, angiodysplasia, hemorrhoids, neoplasm, colitis
- Endoscopic therapy if active bleeding or stigmata
- ◆Decision
Bleeding Source Identified?
Colonoscopy findings
- ●Action
Endoscopic Therapy
If active bleeding or stigmata
- Clips, thermal coagulation, or injection
- Combination therapy for high-risk lesions
- Tattoo lesion for localization if surgery needed
- ◆Decision
Rebleeding?
Monitor for recurrence
- ⚠Warning
Angiography or Surgery
For refractory bleeding
- CTA to localize if bleeding rate >0.5 mL/min
- Angioembolization if source identified
- Surgery if angiography fails or unavailable
- ✓Outcome
Discharge
Stable, no rebleeding
- Address underlying cause
- Review anticoagulation/antiplatelet
- GI follow-up
- Return precautions
- ●Action
No Source Identified
Further workup
- If ongoing bleeding: CT angiography or tagged RBC scan
- Capsule endoscopy for occult/obscure bleeding
- Consider upper endoscopy if not done
- ●Action
Risk Stratification
Identify high-risk features
- Oakland Score recommended
- HIGH RISK: Hemodynamic instability, ongoing bleeding, Hgb <7, comorbidities, anticoagulation
- LOW RISK: Oakland ≤8, no high-risk features
- ●Action
Low Risk (Oakland ≤8)
May consider outpatient management
- Outpatient colonoscopy within 7 days
- Discharge with clear instructions
- Return if recurrent bleeding
Guideline Source
ACG Clinical Guideline: Management of Patients With Acute Lower GI Bleeding 2023
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Does not address obscure GI bleeding in detail
- Risk stratification should be formalized with validated scores
- Colonoscopy timing depends on local resources
- Anticoagulation management requires multidisciplinary input
Contraindicated Populations
Applicable Regions
US: ACG 2023 is current standard
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Lower GI Bleeding Management (ACG 2023)?
The Lower GI Bleeding Management (ACG 2023) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on ACG Clinical Guideline: Management of Patients With Acute Lower GI Bleeding 2023.
What guideline is the Lower GI Bleeding Management (ACG 2023) based on?
This algorithm is based on ACG Clinical Guideline: Management of Patients With Acute Lower GI Bleeding 2023 (DOI: 10.14309/ajg.0000000000002297).
What are the limitations of the Lower GI Bleeding Management (ACG 2023)?
Known limitations include: Does not address obscure GI bleeding in detail; Risk stratification should be formalized with validated scores; Colonoscopy timing depends on local resources; Anticoagulation management requires multidisciplinary input. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Lower GI Bleeding Management (ACG 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free